mTORC2 promotes pancreatic cancer progression and parp inhibitor resistance
Chiwen Bu(Zhongda Hospital Southeast University), Jiahua Zhou(Zhongda Hospital Southeast University)
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
January 1, 2023
Cited by 6
Related Papers
The role of the fat mass and obesity‑associated protein in the proliferation of pancreatic cancer cells
|Oncology Letters|2018|73
BRD4 induces cell migration and invasion in HCC cells through MMP-2 and MMP-9 activation mediated by the Sonic hedgehog signaling pathway
|Oncology Letters|2015|71
Long non‑coding RNA CASC2 suppresses pancreatic cancer cell growth and progression by regulating the miR‑24/MUC6 axis
|International Journal of Oncology|2019|29